GLENMARK - Mastering the Cup PatternClassic patterns work because human psychology repeats itself. Let the deep "cup" build a strong foundation, wait for the "handle" to shake out weak hands, and trade the breakout.
Long
Glenmark Pharmaceuticals Limited
No trades
Last report date
Jun 1, 2026
Report period
Q4 2025
EPS
10.68 INR
Revenue
37.71 B INR
48.25 INR
13.62 B INR
169.83 B INR
144.02 M
About Glenmark Pharmaceuticals Limited
Sector
Industry
CEO
Glenn Mario Saldanha
Website
Headquarters
Mumbai
Founded
1977
IPO date
Dec 10, 1999
Identifiers
2
ISIN INE935A01035
Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. It operates through the following geographical segments: India, North America, Europe, Latin America, and Rest of the World. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India.
Related stocks
Long
inverse head & shoulders Breakdown SetupA classic Inverse Head & Shoulders pattern spotted on the chart — a powerful bullish reversal pattern after a downtrend.
Left Shoulder: First dip followed by a bounce
• Head: Deeper low showing the final selling pressure
• Right Shoulder: Higher low indicating sellers are weakening
• Neckline: Key
GLENMARK BREAKOUTLast week, price has closed above the upper trendline of a horizontal channel — a strong bullish signal.
Key Highlights:
✔ Breakout confirmed on weekly timeframe
✔ 50% Fibonacci retracement acted as strong support
✔ Volume expansion supports the move
What to Expect:
• Momentum likely to continue a
Long
Glenmark 75minsGlenmark pharma 75mins is in downtrend.. Closing at trend line resistance.. If bearish candlestick pattern formed can give 9 to 12% down fall
Short
Glenmark Pharma_Weekly Chart Analysis 1️⃣ Trend Structure
* The stock has formed a strong bullish structure after breaking a long-term descending trendline (visible from previous highs).
* A trend reversal occurred near ₹1,300–₹1,350 zone followed by a sharp impulsive rally.
* Price is now trading near lifetime/major swing resistance
Weekly Supply + RSI Divergence | Big Decision Zone on GlenmarkGlenmark Pharmaceuticals has rallied strongly and is now approaching a key Weekly Supply Zone, an area where institutional selling pressure may emerge.
What makes this zone more interesting is the bearish RSI divergence forming on the weekly timeframe. While price is making higher highs, RSI is fai
Short
Glenmark is showing strength, looks it has formed inverted H&SIn daily timeframe, The stock has made inverted H&S, currently testing the BO level, If goes up, It may go to 2417.
And simultaneously , if it does that, it will give a BO of Big rounding bottom which is at 2286, then it may go to 2774.
MACD +ve in +zone.
RSI>60
Long
glenmark ideaSTARTING FROM MARCH 20
5 wave upmove i labbed as A as b time is not half+8
then c was completed in up 5 wave move near oct 2024
in which we have zig zag and irregular correctio marked also shown
in the chart is the base channel and 2-4 trendline which
was broken leading to degree fall
in which w
GLENMARK 1 Month Time Frame 📍 Current Price Context
Price around ₹2,000 – ₹2,030 (recent trading zone) on the NSE.
52-week range roughly ₹1,275 – ₹2,284 indicating broader volatility context.
📈 1-Month Key Levels (Support / Resistance)
🛑 Resistance Levels
These price areas where the stock has historically faced selli
Long
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of GLENMARK is 2,169.65 INR — it has increased by 1.21% in the past 24 hours. Watch Glenmark Pharmaceuticals Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange Glenmark Pharmaceuticals Limited stocks are traded under the ticker GLENMARK.
GLENMARK stock has fallen by −0.55% compared to the previous week, the month change is a −2.81% fall, over the last year Glenmark Pharmaceuticals Limited has showed a 34.13% increase.
We've gathered analysts' opinions on Glenmark Pharmaceuticals Limited future price: according to them, GLENMARK price has a max estimate of 2,750.00 INR and a min estimate of 2,100.00 INR. Watch GLENMARK chart and read a more detailed Glenmark Pharmaceuticals Limited stock forecast: see what analysts think of Glenmark Pharmaceuticals Limited and suggest that you do with its stocks.
GLENMARK reached its all-time high on Apr 29, 2026 with the price of 2,471.05 INR, and its all-time low was 19.65 INR and was reached on Nov 5, 2003. View more price dynamics on GLENMARK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GLENMARK stock is 1.66% volatile and has beta coefficient of 0.14. Track Glenmark Pharmaceuticals Limited stock price on the chart and check out the list of the most volatile stocks — is Glenmark Pharmaceuticals Limited there?
Today Glenmark Pharmaceuticals Limited has the market capitalization of 613.28 B, it has decreased by −1.11% over the last week.
Yes, you can track Glenmark Pharmaceuticals Limited financials in yearly and quarterly reports right on TradingView.
Glenmark Pharmaceuticals Limited is going to release the next earnings report on Aug 13, 2026. Keep track of upcoming events with our Earnings Calendar.
GLENMARK net income for the last quarter is 3.01 B INR, while the quarter before that showed 4.03 B INR of net income which accounts for 0.00% change. Track more Glenmark Pharmaceuticals Limited financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Glenmark Pharmaceuticals Limited EBITDA is 39.82 B INR, and current EBITDA margin is 26.92%. See more stats in Glenmark Pharmaceuticals Limited financial statements.
Like other stocks, GLENMARK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Glenmark Pharmaceuticals Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Glenmark Pharmaceuticals Limited technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Glenmark Pharmaceuticals Limited stock shows the buy signal. See more of Glenmark Pharmaceuticals Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.